NCT00473590 2017-06-14
AMBER
Genentech, Inc.
Phase 2 Completed
Clinical Trials
3 trialsNCT00022607 2013-06-24
Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00482495 2011-05-11
Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Mayo Clinic
Phase 2 Completed